Nordea Investment Management Ab Myriad Genetics Inc Transaction History

Nordea Investment Management Ab

  • $92.4 Billion
  • Q4 2024

A detailed history of Nordea Investment Management Ab transactions in Myriad Genetics Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 332,913 shares of MYGN stock, worth $3.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
332,913
Previous 153,386 117.04%
Holding current value
$3.44 Million
Previous $4.2 Million 8.72%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025
BUY
$13.17 - $27.03 $2.36 Million - $4.85 Million
179,527 Added 117.04%
332,913 $4.56 Million
Q3 2024

Nov 05, 2024
SELL
$23.97 - $28.6 $197,896 - $236,121
-8,256 Reduced 5.11%
153,386 $4.2 Million
Q2 2024

Aug 08, 2024
BUY
$17.98 - $25.47 $588,647 - $833,862
32,739 Added 25.4%
161,642 $3.95 Million
Q1 2024

May 02, 2024
BUY
$17.59 - $23.59 $119,735 - $160,577
6,807 Added 5.58%
128,903 $2.75 Million
Q4 2023

Jan 10, 2024
SELL
$13.91 - $21.32 $72,512 - $111,141
-5,213 Reduced 4.09%
122,096 $2.34 Million
Q3 2023

Nov 13, 2023
SELL
$15.99 - $23.22 $72,498 - $105,279
-4,534 Reduced 3.44%
127,309 $2.04 Million
Q2 2023

Jul 07, 2023
SELL
$17.56 - $23.76 $832,730 - $1.13 Million
-47,422 Reduced 26.45%
131,843 $3.06 Million
Q1 2023

Apr 19, 2023
SELL
$15.26 - $23.75 $42,239 - $65,740
-2,768 Reduced 1.52%
179,265 $4.16 Million
Q4 2022

Feb 08, 2023
SELL
$14.51 - $20.99 $277,082 - $400,825
-19,096 Reduced 9.49%
182,033 $2.64 Million
Q3 2022

Oct 19, 2022
SELL
$18.21 - $27.88 $19,466 - $29,803
-1,069 Reduced 0.53%
201,129 $3.98 Million
Q2 2022

Aug 09, 2022
SELL
$16.45 - $25.88 $358,165 - $563,485
-21,773 Reduced 9.72%
202,198 $3.67 Million
Q1 2022

Apr 11, 2022
BUY
$22.67 - $28.01 $69,120 - $85,402
3,049 Added 1.38%
223,971 $5.78 Million
Q4 2021

Jan 20, 2022
SELL
$24.13 - $32.63 $40,272 - $54,459
-1,669 Reduced 0.75%
220,922 $6.26 Million
Q3 2021

Nov 01, 2021
SELL
$29.97 - $36.66 $6.67 Million - $8.16 Million
-222,591 Reduced 50.0%
222,591 $7.36 Million
Q3 2021

Nov 01, 2021
BUY
$29.97 - $36.66 $6.77 Million - $8.28 Million
225,740 Added 102.87%
445,182 $14.4 Million
Q2 2021

Jul 16, 2021
BUY
$25.39 - $32.61 $2.12 Million - $2.72 Million
83,448 Added 61.36%
219,442 $6.71 Million
Q1 2021

May 17, 2021
SELL
$19.92 - $31.6 $46,314 - $73,470
-2,325 Reduced 1.68%
135,994 $4.07 Million
Q4 2020

Feb 12, 2021
SELL
$12.16 - $19.77 $44,797 - $72,832
-3,684 Reduced 2.59%
138,319 $2.74 Million
Q3 2020

Nov 09, 2020
SELL
$11.25 - $14.75 $1.6 Million - $2.09 Million
-142,003 Reduced 50.0%
142,003 $1.85 Million
Q2 2020

Aug 13, 2020
BUY
$10.69 - $16.49 $1.55 Million - $2.39 Million
144,820 Added 104.05%
284,006 $3.22 Million
Q1 2020

May 15, 2020
BUY
$9.78 - $29.53 $40,049 - $120,925
4,095 Added 3.03%
139,186 $2.05 Million
Q4 2019

Feb 11, 2020
BUY
$20.93 - $35.1 $85,854 - $143,980
4,102 Added 3.13%
135,091 $3.63 Million
Q3 2019

Nov 13, 2019
BUY
$22.08 - $47.08 $20,291 - $43,266
919 Added 0.71%
130,989 $3.75 Million
Q2 2019

Aug 14, 2019
SELL
$22.67 - $35.0 $27,181 - $41,965
-1,199 Reduced 0.91%
130,070 $3.61 Million
Q1 2019

May 20, 2019
BUY
$26.93 - $34.7 $660,108 - $850,566
24,512 Added 22.96%
131,269 $4.36 Million
Q4 2018

Feb 14, 2019
BUY
$27.23 - $45.56 $143,611 - $240,283
5,274 Added 5.2%
106,757 $3.1 Million
Q3 2018

Nov 14, 2018
BUY
$37.57 - $50.34 $729,496 - $977,451
19,417 Added 23.66%
101,483 $4.67 Million
Q2 2018

Aug 13, 2018
SELL
$27.75 - $40.17 $133,505 - $193,257
-4,811 Reduced 5.54%
82,066 $3.07 Million
Q1 2018

May 14, 2018
BUY
$28.83 - $41.01 $449,719 - $639,714
15,599 Added 21.88%
86,877 $2.57 Million
Q4 2017

Feb 12, 2018
SELL
$28.45 - $37.14 $196,305 - $256,266
-6,900 Reduced 8.83%
71,278 $2.45 Million
Q3 2017

Nov 09, 2017
BUY
$24.01 - $36.2 $1.88 Million - $2.83 Million
78,178
78,178 $2.83 Million

Others Institutions Holding MYGN

# of Institutions
228
Shares Held
92M
Call Options Held
297K
Put Options Held
20.7K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $834M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email